Kavanagh EL - Search Results

1

Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis.

Guang MHZ, Kavanagh EL, Dunne LP, Dowling P, Zhang L, Lindsay S, Bazou D, Goh CY, Hanley C, Bianchi G, Anderson KC, O'Gorman P, McCann A. Guang MHZ, et al. Among authors: kavanagh el. Cancers (Basel). 2019 Jan 9;11(1):66. doi: 10.3390/cancers11010066. Cancers (Basel). 2019. PMID: 30634515 Free PMC article. Review.

2

Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells.

Kavanagh EL, Lindsay S, Halasz M, Gubbins LC, Weiner-Gorzel K, Guang MHZ, McGoldrick A, Collins E, Henry M, Blanco-Fernández A, O Gorman P, Fitzpatrick P, Higgins MJ, Dowling P, McCann A. Kavanagh EL, et al. Oncogenesis. 2017 Oct 9;6(10):e388. doi: 10.1038/oncsis.2017.82. Oncogenesis. 2017. PMID: 28991260 Free PMC article.

3

Resident bacteria in breast cancer tissue: pathogenic agents or harmless commensals?

O'Connor H, MacSharry J, Bueso YF, Lindsay S, Kavanagh EL, Tangney M, Clyne M, Saldova R, McCann A. O'Connor H, et al. Among authors: kavanagh el. Discov Med. 2018 Sep;26(142):93-102. Discov Med. 2018. PMID: 30399327 Free article. Review.

4

Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling.

Ho M, Chen T, Liu J, Dowling P, Hideshima T, Zhang L, Morelli E, Camci-Unal G, Wu X, Tai YT, Wen K, Samur M, Schlossman RL, Mazitschek R, Kavanagh EL, Lindsay S, Harada T, McCann A, Anderson KC, O'Gorman P, Bianchi G. Ho M, et al. Among authors: kavanagh el. Leukemia. 2020 Jan;34(1):196-209. doi: 10.1038/s41375-019-0493-x. Epub 2019 May 29. Leukemia. 2020. PMID: 31142847 Free PMC article.

5

N-Linked glycosylation profiles of therapeutic induced senescent (TIS) triple negative breast cancer cells (TNBC) and their extracellular vesicle (EV) progeny.

Kavanagh EL, Halasz M, Dowling P, Withers J, Lindsay S, Higgins MJ, Irwin JA, Rudd PM, Saldova R, McCann A. Kavanagh EL, et al. Mol Omics. 2021 Feb 1;17(1):72-85. doi: 10.1039/d0mo00017e. Epub 2020 Dec 16. Mol Omics. 2021. PMID: 33325943

6

Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells.

Liu Z, Krstic A, Neve A, Casalou C, Rauch N, Wynne K, Cassidy H, McCann A, Kavanagh E, McCann B, Blanco A, Rauch J, Kolch W. Liu Z, et al. Int J Mol Sci. 2023 Jul 23;24(14):11821. doi: 10.3390/ijms241411821. Int J Mol Sci. 2023. PMID: 37511580 Free PMC article.

7

The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells.

AlSultan D, Kavanagh E, O'Grady S, Eustace AJ, Castell A, Larsson LG, Crown J, Madden SF, Duffy MJ. AlSultan D, et al. Invest New Drugs. 2021 Apr;39(2):587-594. doi: 10.1007/s10637-020-01018-w. Epub 2020 Oct 14. Invest New Drugs. 2021. PMID: 33052557

8

Microbial biotransformation of aryl sulfanylpentafluorides.

Kavanagh E, Winn M, Gabhann CN, O'Connor NK, Beier P, Murphy CD. Kavanagh E, et al. Environ Sci Pollut Res Int. 2014 Jan;21(1):753-8. doi: 10.1007/s11356-013-1985-2. Epub 2013 Jul 20. Environ Sci Pollut Res Int. 2014. PMID: 23872898

9

An assessment of the performance of municipal constructed wetlands in Ireland.

Hickey A, Arnscheidt J, Joyce E, O'Toole J, Galvin G, O' Callaghan M, Conroy K, Killian D, Shryane T, Hughes F, Walsh K, Kavanagh E. Hickey A, et al. J Environ Manage. 2018 Mar 15;210:263-272. doi: 10.1016/j.jenvman.2017.12.079. J Environ Manage. 2018. PMID: 29367139 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page